Scholars Central

Conference abstractPublished 2013

Resveratrol targets retinoic acid signaling to prevent neural tube defects in a rodent model of diabetic embryopathy

Authors: Ugra S. Singh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Approximately 26 million Americans suffer from diabetes. In females, the problem is further aggravated by the fact that diabetes also affects embryonic development during pregnancy and causes embryonic defects known as diabetic embryopathy. Various birth defects, such as neural tube defects (NTDs), are reported to be associated with diabetic embryopathy. However, preventive measures and available therapies are not fully effective. Currently, resveratrol found in blueberries and red grapes is the focus of intense research and toted as a potential complementary and alternative medicine for the treatment of various diseases. It has shown promising results in the management of diabetes and prevention of diabetic complications. Using a rodent model of diabetic embryopathy, our studies have shown that resveratrol functions as a potent antioxidant. It protects embryos from oxidative stress and prevents apoptosis. Interestingly, resveratrol also prevents neural tube defects in the embryos. It reduces blood sugar and improves lipid profile of diabetic dams. Retinoic acid signaling components such as retinoic acid receptors and Rho GTPases play key roles in neural tube closing, and hyperglycemia impairs the expression and activation of retinoic acid receptors in the embryos of diabetic dams. Since resveratrol is a potent antioxidant, it may target retinoic acid signaling to prevent diabetic embryopathy and other complications such as nephropathy in diabetic pregnancies. Presently, our studies are focused to elucidate mechanistic pathways and gene targets of resveratrol which will serve as the basis for future clinical studies on the prevention of neural tube defects in diabetic embryopathy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Ugra S. Singh”